GNFT.PA
Genfit SA
Price:  
8.49 
EUR
Volume:  
339,119.00
France | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GNFT.PA Relative Valuation

-143.4%
Upside

As of 2026-03-14, the Relative Valuation of Genfit SA (GNFT.PA) is (3.68) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 8.49 EUR, the upside of Genfit SA based on Relative Valuation is -143.4%.

The range of the Relative Valuation is (5.25) - 0.92 EUR.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 6.7x - 10.3x 10.1x
Forward P/E multiples 11.0x - 22.0x 12.0x
Fair Price (5.25) - 0.92 (3.68)
Upside -161.8% - -89.2% -143.4%
8.49 EUR
Stock Price
(3.68) EUR
Fair Price

GNFT.PA Relative Valuation - Historical P/E Data

Date P/E
2026-03-13 -10.98
2026-03-12 -11.18
2026-03-11 -11.52
2026-03-10 -12.02
2026-03-09 -11.43
2026-03-06 -10.94
2026-03-05 -11.23
2026-03-04 -11.09
2026-03-03 -10.89
2026-03-02 -11.42
2026-02-27 -11.54
2026-02-26 -11.36
2026-02-25 -11.66
2026-02-24 -11.67
2026-02-23 -11.19
2026-02-20 -10.12
2026-02-19 -10.46
2026-02-18 -10.10
2026-02-17 -10.31
2026-02-16 -9.81
2026-02-13 -9.16
2026-02-12 -9.15
2026-02-11 -8.63
2026-02-10 -8.38
2026-02-09 -8.03
2026-02-06 -7.83
2026-02-05 -8.12
2026-02-04 -7.94
2026-02-03 -8.27
2026-02-02 -7.48
2026-01-30 -7.19
2026-01-29 -7.26
2026-01-28 -7.32
2026-01-27 -7.24
2026-01-26 -7.06
2026-01-23 -7.14
2026-01-22 -7.12
2026-01-21 -6.76
2026-01-20 -6.70
2026-01-19 -6.78
2026-01-16 -6.76
2026-01-15 -6.94
2026-01-14 -6.97
2026-01-13 -6.79
2026-01-12 -6.78
2026-01-09 -6.82
2026-01-08 -6.74
2026-01-07 -6.89
2026-01-06 -6.81
2026-01-05 -6.65